AMG-436

N/A

Report date: 2026/05/25 20:02:40

Base Information

Drug NameAMG-436
Drug Alias NameAMG 436AMG436AMG-436
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursMicrosatellite instability-high cancerMismatch Repair Deficient Cancer +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmgen IncAmgen Biotechnology Consultation (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursMicrosatellite instability-high cancerMismatch Repair Deficient Cancer +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A